{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:15:59Z","timestamp":1778566559484,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013213","name":"ARUP Institute for Clinical and Experimental Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jim.2025.113882","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:13:41Z","timestamp":1747941221000},"page":"113882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Validation for soluble C5b-9 detection and comparative analysis of three quantification methods"],"prefix":"10.1016","volume":"541","author":[{"given":"Tracie","family":"Profaizer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Saadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayalakshmi","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2025.113882_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585108","article-title":"Soluble membrane attack complex: biochemistry and Immunobiology","volume":"11","author":"Barnum","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2025.113882_bb0010","series-title":"Evaluation of Detection Capacity for Clinical Laboratory Procedures; Approved Guideline-Second Edition","author":"CLSI","year":"2012"},{"key":"10.1016\/j.jim.2025.113882_bb0015","series-title":"CLSI guideline EP06","article-title":"Evaluation of linearity of quantitative measurement procedures","author":"CLSI","year":"2020"},{"key":"10.1016\/j.jim.2025.113882_bb0020","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1073\/pnas.74.4.1683","article-title":"Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms","volume":"74","author":"Fearon","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jim.2025.113882_bb0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic Microangiopathy after stem cell transplantation","volume":"24","author":"Horv\u00e1th","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jim.2025.113882_bb0030","first-page":"735","article-title":"Complement: activation, consequences, and control","volume":"48","author":"James","year":"1982","journal-title":"Am. J. Med. Technol."},{"key":"10.1016\/j.jim.2025.113882_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jim.2025.113882_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"Diagnosis and management of HSCT-associated thrombotic microangiopathy as multisystem endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.jim.2025.113882_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable Eculizumab clearance requires Pharmacodynamic monitoring to optimize therapy for thrombotic Microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jim.2025.113882_bb0050","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"issue":"392","key":"10.1016\/j.jim.2025.113882_bb0055","first-page":"e391","article-title":"Transplantation-associated thrombotic Microangiopathy risk stratification: is there a window of opportunity to improve outcomes?","volume":"28","author":"Jodele","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jim.2025.113882_bb0060","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2025.113882_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109871","article-title":"Differential contributions of the C5b-9 and C5a\/C5aR pathways to microvascular and macrovascular thrombosis in complement-mediated thrombotic microangiopathy patients","volume":"259","author":"Liu","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113882_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2025.113882_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.569291","article-title":"Validation of early increase in complement activation marker sC5b-9 as a predictive biomarker for the development of thrombotic Microangiopathy after stem cell transplantation","volume":"7","author":"Mez\u00f6","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.jim.2025.113882_bb0080","doi-asserted-by":"crossref","first-page":"47s","DOI":"10.1111\/1523-1747.ep12275445","article-title":"The killer molecule of complement","volume":"85","author":"M\u00fcller-Eberhard","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jim.2025.113882_bb0085","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2025.113882_bb0090","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jim.2025.113882_bb0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jim.2025.113882_bb0100","author":"QuidelOrtho MicroVue SC5b-9 Plus EIA package insert"},{"key":"10.1016\/j.jim.2025.113882_bb0105","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jim.2025.113882_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jim.2025.113882_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2025.113882_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2025.113882_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2018.06.010","article-title":"The impact of eculizumab on routine complement assays","volume":"460","author":"Willrich","year":"2018","journal-title":"J. Immunol. Methods"},{"issue":"120127","key":"10.1016\/j.jim.2025.113882_bb0130","article-title":"Validation and performance of MicroVue sC5b-9 plus ELISA on the Dynex DS2 platform","volume":"568","author":"Wilson","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jim.2025.113882_bb0135","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jim.2025.113882_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.612402","article-title":"Monoclonal antibodies capable of inhibiting complement downstream of C5 in multiple species","volume":"11","author":"Zelek","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2025.113882_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol. Immunol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:41:16Z","timestamp":1778564476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175925000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"alternative-id":["S0022175925000821"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2025.113882","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation for soluble C5b-9 detection and comparative analysis of three quantification methods","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2025.113882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113882"}}